AAAAAA

   
Results: 1-10 |
Results: 10
EFFECTS OF CANDESARTAN CILEXETIL IN PATIENTS WITH SYSTEMIC HYPERTENSION
Authors: REIF M WHITE WB FAGAN TC OPARIL S FLANAGAN TL EDWARDS DT CUSHING DJ MICHELSON EL
Citation: M. Reif et al., EFFECTS OF CANDESARTAN CILEXETIL IN PATIENTS WITH SYSTEMIC HYPERTENSION, The American journal of cardiology, 82(8), 1998, pp. 961-965
EVOLUTION OF THE JOINT-NATIONAL-COMMITTEE REPORTS, 1988-1997 - EVOLUTION OF THE SCIENCE OF TREATING HYPERTENSION
Authors: FAGAN TC
Citation: Tc. Fagan, EVOLUTION OF THE JOINT-NATIONAL-COMMITTEE REPORTS, 1988-1997 - EVOLUTION OF THE SCIENCE OF TREATING HYPERTENSION, Archives of internal medicine, 157(21), 1997, pp. 2401-2402
BLOOD-PRESSURE REDUCTION AND TOLERABILITY OF FELODIPINE ER IN OLDER AND YOUNGER HYPERTENSIVE PATIENTS
Authors: FAGAN TC
Citation: Tc. Fagan, BLOOD-PRESSURE REDUCTION AND TOLERABILITY OF FELODIPINE ER IN OLDER AND YOUNGER HYPERTENSIVE PATIENTS, Journal of the American Geriatrics Society, 45(6), 1997, pp. 712-717
STIMULATORY AS WELL AS INHIBITORY EFFECTS OF ETHINYLESTRADIOL ON THE METABOLIC CLEARANCES OF PROPRANOLOL IN YOUNG-WOMEN
Authors: WALLE T FAGAN TC WALLE UK TOPMILLER MJ
Citation: T. Walle et al., STIMULATORY AS WELL AS INHIBITORY EFFECTS OF ETHINYLESTRADIOL ON THE METABOLIC CLEARANCES OF PROPRANOLOL IN YOUNG-WOMEN, British journal of clinical pharmacology, 41(4), 1996, pp. 305-309
TREATMENT OF MILD HYPERTENSION WITH LOW ONCE-DAILY DOSES OF A SUSTAINED-RELEASE CAPSULE FORMULATION OF VERAPAMIL
Authors: DAVIS PJ FAGAN TC TOPMILLER MJ LEVINE JH FERDINAND KC
Citation: Pj. Davis et al., TREATMENT OF MILD HYPERTENSION WITH LOW ONCE-DAILY DOSES OF A SUSTAINED-RELEASE CAPSULE FORMULATION OF VERAPAMIL, Journal of clinical pharmacology, 35(1), 1995, pp. 52-58
CALCIUM-ANTAGONISTS AND MORTALITY - ANOTHER CASE OF THE NEED FOR CLINICAL JUDGMENT
Authors: FAGAN TC
Citation: Tc. Fagan, CALCIUM-ANTAGONISTS AND MORTALITY - ANOTHER CASE OF THE NEED FOR CLINICAL JUDGMENT, Archives of internal medicine, 155(20), 1995, pp. 2145-2145
THE INFLUENCE OF GENDER AND SEX STEROID-HORMONES ON THE PLASMA-BINDING OF PROPRANOLOL ENANTIOMERS
Authors: WALLE UK FAGAN TC TOPMILLER MJ CONRADI EC WALLE T
Citation: Uk. Walle et al., THE INFLUENCE OF GENDER AND SEX STEROID-HORMONES ON THE PLASMA-BINDING OF PROPRANOLOL ENANTIOMERS, British journal of clinical pharmacology, 37(1), 1994, pp. 21-25
EFFICACY AND TOLERABILITY OF EXTENDED-RELEASE FELODIPINE AND EXTENDED-RELEASE NIFEDIPINE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
Authors: FAGAN TC HAGGERT BE LISS C
Citation: Tc. Fagan et al., EFFICACY AND TOLERABILITY OF EXTENDED-RELEASE FELODIPINE AND EXTENDED-RELEASE NIFEDIPINE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, Clinical therapeutics, 16(4), 1994, pp. 634-646
REMEMBERING THE LESSONS OF BASIC PHARMACOLOGY
Authors: FAGAN TC
Citation: Tc. Fagan, REMEMBERING THE LESSONS OF BASIC PHARMACOLOGY, Archives of internal medicine, 154(13), 1994, pp. 1430-1431
SUSTAINED-RELEASE NICARDIPINE IN MILD-TO-MODERATE HYPERTENSION
Authors: FAGAN TC TYLER ED REITMAN MA KENLEY S WEBER MA
Citation: Tc. Fagan et al., SUSTAINED-RELEASE NICARDIPINE IN MILD-TO-MODERATE HYPERTENSION, Chest, 104(2), 1993, pp. 427-433
Risultati: 1-10 |